Molecular Cytogenetics Market- Global Opportunity Analysis And Industry Forecasts To 2022
Global Molecular Cytogenetics Market Size by Technique (Fluorescence In Situ Hybridization, Comparative Genomic Hybridization, In situ Hybridization, Karyotyping, and Banding Techniques), by Product (Instruments, Kits and Reagents, Software, Services, and Consumables/Accessories ), by Application (Oncology, Genetic Disorders, Personalized Medicines, and others), by End User (Pharmaceuticals and Biotechnology Companies, Clinical and Diagnostic Laboratories, and Academic Institutes) Global Opportunity Analysis and Industry Forecasts To 2022
Global molecular cytogenetics market is expected to reach USD 2,266.4 million by 2022, supported by a CAGR of 11% during the forecast period of 2017 to 2022. The global molecular cytogenetics market is mainly driven by increasing focus on preventive healthcare measures, increasing genetic abnormalities, rising aging population and subsequent increase in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis. Moreover, increasing focus on targeted based therapies and growing predictive and presymptomatic genetic testing further provides significant opportunities in this market. However, lack of awareness about emerging diagnosis technologies, high cost of diagnosis, unfavourable reimbursement scenario, and technical limitations and complexities of the equipment inhibits the growth of the market to some extent.
The global molecular cytogenetics market is mainly segmented by technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding techniques), by product (instruments, kits and reagents, software, services, and consumable/accessories ), by application (oncology, genetic disorders, personalized medicines, and other), and by end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes).
Global Molecular Cytogenetics Market, by Application, 2017- 2022
Molecular cytogenetics market
Source: Meticulous Research Analysis
Geographically, the global molecular cytogenetics market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global molecular cytogenetics market in 2016, followed by Europe, and Asia-Pacific region. The large share of this region is primarily attributed to the increased funding in medical research, stringent drug development regulations which demand molecular cytogenetics techniques, growing aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech companies.
However, Asia-Pacific region possesses lucrative growth potential for the molecular cytogenetic market during the forecast period owing to the increasing demand in China and India, growing population, various technological advancements, growing investment from government & non-government bodies, and growing pharma biotech industry in the region.
The key players in the global molecular cytogenetics market are Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, Applied Spectral Imaging, Quest Diagnostics, Roche Diagnostics, Danaher Corporation, Illumina, and Oxford Gene Technology.
Scope of the Report
Market by Technique: